Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans

Stem Cells

Volumn 27, Issue 6, 2009, Pages 1421-1432

  Sun, Lingyun ^a   Akiyama, Kentaro ^b   Zhang, Huayong ^a   Yamaza, Takayoshi ^b   Hou, Yayi ^a   Zhao, Shengnan ^a   Xu, Ting ^a   Le, Anh ^b   Shi, Songtao ^b  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Bone marrow mesenchymal stem cells; Systemic lupus erythematosus; Transplantation

Indexed keywords

CD4 ANTIGEN; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; INTERLEUKIN 2 RECEPTOR ALPHA; PREDNISONE; TRANSCRIPTION FACTOR FOXP3;

ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CASE REPORT; CELL FUNCTION; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MESENCHYMAL STEM CELL; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; OSTEOBLAST; OSTEOPOROSIS; OUTCOME ASSESSMENT; PATHOGENESIS; PLASMA CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TH17 CELL;

ADOLESCENT; ANIMALS; AUTOANTIBODIES; BLOTTING, WESTERN; BONE MARROW TRANSPLANTATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED MRL LPR; PILOT PROJECTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELL NICHE; YOUNG ADULT;

MUS;

EID: 67649604299     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.68     Document Type: Article

References (51)

1. Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med 2008;358:929-939.
2. Kyttaris VC, Juang YT, Tsokos GC. Immune cells and cytokines in systemic lupus erythematosus: An update. Curr Opin Rheumatol 2005;17:518-522. (Pubitemid 41527809)
3. Crispin JC, Tsokos GC. Novel molecular targets in the treatment of systemic lupus erythematosus. Autoimmun Rev 2008;7:256-261.
4. Ramanujam M, Davidson A. Targeting of the immune system in systemic lupus erythematosus. Expert Rev Mol Med 2008;21:10, e2.
5. Pego-Reigosa JM, Isenberg DA. System in systemic lupus erythematosus: Pharmacological developments and recommendations for a therapeutic strategy. Expert Opin Investig Drugs 2008;17:31-41. (Pubitemid 351578209)
6. Tieng AT, Peeva E. B-cell-directed therapies in systemic lupus erythematosus. Semin Arthritis Rheum 2008;38:218-227.
7. Burt RK, Traynor A, Statkute L et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. Jama 2006;295:527-535. (Pubitemid 43200347)
8. Smith-Berdan S, Gille D, Weissman IL et al. Reversal of autoimmune disease in lupus-prone New Zealand black/New Zealand white mice by nonmyeloablative transplantation of purified allogeneic hematopoietic stem cells. Blood 2007;110:1370-1378. (Pubitemid 47281439)
9. Friedenstein AJ, Chailakhyan RK, Latsinik NV et al. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues.Cloning in vitro and retransplantation in vivo. Transplantation 1974;17:331-340.
10. Owen M, Friedenstein AJ. Stromal stem cells: Marrow-derived osteogenic precursors. Ciba Found Symp 1998;136:42-60.
11. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997;276:71-74. (Pubitemid 27161245)
12. Zhang J, Niu C, Ye L et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003;425:836-841. (Pubitemid 37351467)
13. Calvi LM, Adams GB, Weibrecht KW et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003;425:841-846. (Pubitemid 37351468)
14. Arai F, Hirao A, Ohmura M et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 2004;118:149-161. (Pubitemid 38962572)
15. Bartholomew A, Sturgeon C, Siatskas M et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002;30:42-48. (Pubitemid 34059216)
16. Uccelli A, Pistoia V, Moretta L. Mesenchymal stem cells: A new strategy for immunosuppression? Trends Immunol 2007;28:219-226.
17. Corcione A, Benvenuto F, Ferretti E et al. Human mesenchymal stem cells modulate B-cell functions. Blood 2006;107:367-372. (Pubitemid 43053565)
18. Rasmusson I, Le Blanc K, Sundberg B et al. Mesenchymal stem cells stimulate antibody secretion in human B cells. Scand J Immunol 2007;65:336-343. (Pubitemid 46481102)
19. Ramasamy R, Fazekasova H, Lam EW et al. Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation 2007;83:71-76. (Pubitemid 46104974)
20. Spaggiari GM, Capobianco A, Becchetti S et al. Mesenchymalstem-cell- natural killer cell interactions: Evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 2006;107:1484-1490. (Pubitemid 43242385)
21. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105:1815-1822. (Pubitemid 40223708)
22. Le Blanc K, Frassoni F, Ball L et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363:1439-1441. (Pubitemid 38586721)
23. Chen X, Armstrong MA, Li G. Mesenchymal stem cells in immunoregulation. Immunol Cell Biol 2006;84:413-421. (Pubitemid 44286034)
24. Koç ON, Gerson SL, Cooper BW et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000;18:307-316. (Pubitemid 30056419)
25. Noort WA, Kruisselbrink AB, in't Anker PS et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34 cells in NOD/SCID mice. Exp Hematol 2002;30:870-878.
26. Miura M, Chen XD, Allen MR et al. A crucial role of Caspase-3 in osteogenic differentiation of bone marrow stromal stem cells. J Clin Invest 2004;114:1704-1713. (Pubitemid 40385526)
27. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
28. Shi S, Gronthos S, Chen S et al. Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression. Nat Biotechnol 2002;20:587-591. (Pubitemid 34595152)
29. Lane NE. Therapy insight: Osteoporosis and osteonecrosis in systemic lupus erythematosus. Nat Clin Pract Rheumatol 2006;2:562-569. (Pubitemid 44489960)
30. Raisz LG. Pathogenesis of osteoporosis:concepts, conflict, and prospects. J Clin Invest 2005;115:3318-3325.
31. Yamaza T, Miura Y, Bi Y et al. Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents. Plos One 2008;3:e2615.
32. Hostmann A, Jacobi AM, Mei H et al. Peripheral B cell abnormalities and disease activity in systemic lupus erythematosus. Lupus 2008;17:1064-1069.
33. La Cava A. T-regulatory cells in systemic lupus erythematosus. Lupus 2008;17:421-425. (Pubitemid 351798720)
34. Garrett-Sinha LA, John S, Gaffen SL. IL-17 and the Th17 lineage in systemic lupus erythematosus. Curr Opin Rheumatol 2008;20:519-525.
35. Sato K, Suematsu A, Okamoto K et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 2006;203:2673-2682. (Pubitemid 44833343)
36. Sun LY, Zhang HY, Feng XB et al. Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Lupus 2007;16:121-128. (Pubitemid 46347934)
37. Sun LY, Zhou KX, Feng XB et al. Abnormal surface markers expression on bone marrow CD34+ cells and correlation with disease activity in patients with systemic lupus erythematosus. Clin Rheumatol 2007;26:2073-2079. (Pubitemid 350120345)
38. El-Badri NS, Hakki A, Ferrari A et al. Autoimmune disease: is it a disorder of the microenvironment? Immunol Res 2008;41:79-86.
39. Cordeiro AC, Isenberg DA. Novel therapies in lupus - Focus on nephritis. Acta Reumatol Port 2008;33:157-169.
40. Drappa J, Brot N, Elkon KB. The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, Mrl lpr/lpr. Proc Natl Acad Sci USA 1993;90:10340-10344. (Pubitemid 23328308)
41. Huang FP, Feng GJ, Lindop G et al. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice. J Exp Med 1996;183:1447-1459. (Pubitemid 26134288)
42. Quarto R, Mastrogiacomo M, Cancedda R et al. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 2001;344:385-386. (Pubitemid 32107654)
43. Neubert K, Meister S, Moser K et al. The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis. Nat Med 2008;14:748-755. (Pubitemid 351951516)
44. Fouillard L, Bensidhoum M, Bories D et al. Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma. Leukemia 2003;17:474-476. (Pubitemid 36266932)
45. Zhou K, Zhang H, Jin O et al. Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice. Cell Mol Immunol 2008;5:417-424.
46. Banham AH, Powrie FM, Suri-Payer E. FOXP3(+) regulatory T cells: Current controversies and future perspectives. Eur J Immunol 2006;36:2832-2836. (Pubitemid 44782555)
47. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299:1057-1061. (Pubitemid 36222930)
48. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nature Immunology 2003;4:330-336.
49. Fontenot JD, Rasmussen JP, Williams LM et al. Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 2005;22:329-341. (Pubitemid 40387475)
50. Suri-Payer E, Fritzsching B. Regulatory T cells in experimental autoimmune disease. Springer Semin Immunopathol 2006;28:3-16. (Pubitemid 44267954)
51. Alvarado-Sánchez B, Hernández-Castro B, Portales-Pérez D et al. Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 2006;27:110-118. (Pubitemid 44528260)